Claim Details
View detailed information about this claim and its related sources.
Claim Information
Complete details about this extracted claim.
- Claim Text
-
“It makes a mockery of science if we’re just going to rubber-stamp things with no data.”
- Simplified Text
-
It makes a mockery of science if we’re just going to rubber-stamp things with no data
- Confidence Score
- 0.950
- Claim Maker
- Dr. Makary
- Context Type
- News Article
- Context Details
-
{ "person_speaking": "Dr. Makary", "statement_context": "rubber-stamping things with no data" } - Subject Tags
- UUID
- a1164c06-8330-41c2-b861-98f73404e579
- Vector Index
- âś— No vector
- Created
- February 15, 2026 at 4:02 PM (6 months ago)
- Last Updated
- February 15, 2026 at 4:02 PM (6 months ago)
Original Sources for this Claim (1)
All source submissions that originally contained this claim.
30
claims
🔥
1 week ago
https://nytimes.com/2026/02/10/health/fda-moderna-mrna-flu-vaccine.html
The FDA rejected Moderna's mRNA flu vaccine, signaling a shift in federal health policy under Health Secretary Robert F. Kennedy Jr. The rejection is based on concerns about the clinical trial's comparison product. Moderna's stock has plummeted since its peak.
Similar Claims (5)
Other claims identified as semantically similar to this one.
-
Simplified: He said We’re not going to rubber-stamp new products that don’t work that fail in a clinical trial6 months ago
-
Simplified: Dr Makary criticized Pfizer’s data in an interview on Fox & Friends in November6 months ago
-
Simplified: There is no standardized way of doing research on this so you cannot compare two snapshots in time6 months ago
-
Simplified: Mr Trump claimed finding had no basis in fact6 months ago
-
“The absence of data should not be interpreted as an absence of mortality,” the report said. 1.000Simplified: Absence of data should not be interpreted as absence of mortality report said6 months ago